KRM 1671

Known as: 25-deacetyl-KRM-1648, KRM-1671, Rifamycin VIII, 25-O-deacetyl-1',4-didehydro-1-deoxy-1,4-dihydro-3'-hydroxy-5'-(4-(2-methylpropyl)-1-piperazinyl)-1-oxo- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-1998
0119981998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Rifalazil is a rifamycin derivative from Kaneka that is in phase II clinical trials for the treatment of Mycobacterium… (More)
Is this relevant?